학술논문
Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopathy/Myocarditis registry of the EURObservational Research Programme of the European Society of Cardiology
Document Type
article
Author
Katarzyna Mizia‐Stec; Alida L.P. Caforio; Philippe Charron; Juan R. Gimeno; Perry Elliott; Juan Pablo Kaski; Aldo P. Maggioni; Luigi Tavazzi; Angelos G. Rigopoulos; Cecile Laroche; Attila Frigy; Elisabetta Zachara; Maria Luisa Pena‐Pena; Akinsanya Olusegun‐Joseph; Yigal Pinto; Simone Sala; Fabrizio Drago; Olga Blagova; Elena Reznik; Michał Tendera
Source
ESC Heart Failure, Vol 7, Iss 6, Pp 3601-3609 (2020)
Subject
Language
English
ISSN
2055-5822
Abstract
Abstract Aims Cardiomyopathies are a heterogeneous group of disorders that increase the risk for atrial fibrillation (AF). The aim of the study is to assess the prevalence of AF, anticoagulation management, and risk of stroke/transient ischaemic attack (TIA) in patients with cardiomyopathy. Methods and results Three thousand two hundred eight consecutive adult patients with cardiomyopathy (34.9% female; median age: 55.0 years) were prospectively enrolled as part of the EURObservational Research Programme Cardiomyopathy/Myocarditis Registry. At baseline, 903 (28.2%) patients had AF (29.4% dilated, 27.5% hypertrophic, 51.5% restrictive, and 14.7% arrhythmogenic right ventricular cardiomyopathy, P